Department of Chemistry, University of Petroleum & Energy Studies, Energy Acres, Dehradun, India.
Department of Chemistry, Uttaranchal University, Dehradun, India.
Arch Pharm (Weinheim). 2023 Sep;356(9):e2300245. doi: 10.1002/ardp.202300245. Epub 2023 Jun 28.
The benzoxazolone nucleus is an ideal scaffold for drug design, owing to its discrete physicochemical profile, bioisosteric preference over pharmacokinetically weaker moieties, weakly acidic behavior, presence of both lipophilic and hydrophilic fragments on a single framework, and a wider choice of chemical modification on the benzene and oxazolone rings. These properties apparently influence the interactions of benzoxazolone-based derivatives with their respective biological targets. Hence, the benzoxazolone ring is implicated in the synthesis and development of pharmaceuticals with a diverse biological profile ranging from anticancer, analgesics, insecticides, anti-inflammatory, and neuroprotective agents. This has further led to the commercialization of several benzoxazolone-based molecules and a few others under clinical trials. Nevertheless, the SAR exploration of benzoxazolone derivatives for the identification of potential "hits" followed by the screening of "leads" provides a plethora of opportunities for further exploration of the pharmacological profile of the benzoxazolone nucleus. In this review, we aim to present the biological profile of different derivatives based on the benzoxazolone framework.
苯并恶唑酮核是药物设计的理想支架,由于其离散的物理化学特性、对药代动力学较弱部分的生物等排偏好、弱酸性行为、在单个框架上同时存在亲脂性和亲水性片段,以及苯并恶唑酮环上有更多的化学修饰选择。这些特性显然影响了基于苯并恶唑酮的衍生物与各自生物靶标的相互作用。因此,苯并恶唑酮环参与了具有广泛生物特性的药物的合成和开发,包括抗癌、镇痛药、杀虫剂、抗炎和神经保护剂。这进一步导致了几种基于苯并恶唑酮的分子的商业化,以及一些其他分子正在临床试验中。然而,对苯并恶唑酮衍生物进行 SAR 探索以确定潜在的“命中物”,然后对“先导物”进行筛选,为进一步探索苯并恶唑酮核的药理学特性提供了大量机会。在这篇综述中,我们旨在介绍基于苯并恶唑酮骨架的不同衍生物的生物学特性。